Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2
about
Cellular and molecular basis of deiodinase-regulated thyroid hormone signalingThe circadian E-box: when perfect is not good enough.Developmental and diurnal dynamics of Pax4 expression in the mammalian pineal gland: nocturnal down-regulation is mediated by adrenergic-cyclic adenosine 3',5'-monophosphate signalingSelective genomic targeting by FRA-2/FOSL2 transcription factor: regulation of the Rgs4 gene is mediated by a variant activator protein 1 (AP-1) promoter sequence/CREB-binding protein (CBP) mechanismAdrenergic inducibility of AP-1 binding in the rat pineal gland depends on prior photoperiodMethionine adenosyltransferase:adrenergic-cAMP mechanism regulates a daily rhythm in pineal expressionFos proteins are not prerequisite for osmotic induction of vasopressin transcription in supraoptic nucleus of rats.Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cellsRat and Syrian hamster: two models for the regulation of AANAT gene expression.Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population.cDNA array analysis of pineal gene expression reveals circadian rhythmicity of the dominant negative helix-loop-helix protein-encoding gene, Id-1.DNA microarray analysis and functional profile of pituitary transcriptome under core-clock protein BMAL1 control.Fos-related antigen 2 controls protein kinase A-induced CCAAT/enhancer-binding protein beta expression in osteoblasts.
P2860
Q24648381-A04A3849-798C-4910-8806-2D8D5DDDCFD5Q27863768-3078B258-B910-4519-8979-6C34007110B0Q28572215-42A17239-4CF9-4336-87EA-33A071BD38F9Q28577552-95EEC8EB-EB3B-4D4D-97E5-06548F099E5CQ28577878-E8700397-3C5B-419C-8757-D51CB788D28EQ28579861-25EDF734-AAB7-49C9-BD8F-EF577DD0EDEAQ36128522-59025605-FC15-4465-95A7-B935B562B375Q36415862-284A0289-4DA7-43CF-AAE2-CD10713952BBQ36474510-FEDD60A1-8A9A-44E4-85BE-D1B58318153AQ37598727-C12EBB9F-0C9B-4DE5-8F70-615949110DF2Q38292011-FD518976-F4F5-4DEB-A9AF-91302285BFF6Q38498427-87DFB36F-1D01-45E0-AB99-AE227D8D4DB7Q40527585-A48C10CF-C6D3-4C21-9B64-BA3379F20612
P2860
Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2
description
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Juni 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/06/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/06/01)
@nl
наукова стаття, опублікована в червні 2001
@uk
مقالة علمية (نشرت في يونيو 2001)
@ar
name
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@ast
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@en
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@nl
type
label
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@ast
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@en
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@nl
prefLabel
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@ast
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@en
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@nl
P2093
P2860
P1476
Tissue-specific transgenic kno ...... ted by dominant negative Fra-2
@en
P2093
P2860
P304
P356
10.1128/MCB.21.11.3704-3713.2001
P407
P577
2001-06-01T00:00:00Z